Delivering ZA to tumor tissues via nanoparticles reduces Ras/ERK1/2/HIF-1a axis activity and P-glycoprotein expression and, as a result, increases the number of DCs and reduces the number of infiltrating Tregs [267]. The gene discussed is MAPK3; the disease is neoplasm.